/EINPresswire.com/ -- CHICAGO, IL--(Marketwired - October 25, 2016) - Advantameds Solutions USA Fund 1, Inc. ("Company") announces the completion of its state of the art investor stock purchase portal https://advantameds.us/squeeze-page-10262753.

The Company appears to be the first structured fund in the "Cannabis Industry" to be registered with the US SEC under Regulation ' A' Tier II. Now any cannabis industry supporter over the age of 18 can become an owner of a piece of cannabis history. As early prospectors in the 1849 "California Gold Rush" became the first to benefit from the gold strike, Advantameds Solutions USA Fund 1, Inc. sees very similar historical attributes.

Even though AdvantaMeds Solutions USA Fund 1, Inc. cannot promise that such results of past events, like the historic California gold strike, are indicative of the cannabis industry future, the Company positioned itself beautifully within this huge growth industry. Now, with the ease of an investment portal, interested parties can take advantage of the Company's offering, and be involved, as such.

The upcoming 2016 U.S Election cycle, some U.S. States have cannabis referendums ranging from medical applications to decriminalization. The changes in attitudes towards cannabis are real, and the Company is very active in this growth industry-cannabis.

The Company's web portal design in itself eliminated one of the biggest challenges for issuers under Regulation 'A' which is the delivery and payment for stock purchases directly from the Company to the participant. Through a secure electronic delivery and signature model, stock purchases go directly to the Company, paying electronically. In turn, the purchasers get back all the necessary proofs of ownership in Advantameds Solutions USA Fund 1, Inc.

The Company is now able to take purchases through the majority of electronic payment solutions, as well as E-checks.

CEO Geoff Thompson stated, "The significance of this investment portal fund to the cannabis industry is monumental... With a culture of millions of Cannabis enthusiasts in the US, individuals and other entities alike can be part of this 'Cannabis Rush.' Our Company's portal, the first of its kind, now allows direct participation, allowing immediate ownership, information, and other Company disclosures in real time."

Social media interactions have ramped up as Advantameds Solutions USA Fund 1, Inc. participates in the legal growth of the cannabis industry.

Nothing herein shall be deemed as an offer to sell securities. "Interested" parties are invited to visit the investment web portal, https://advantameds.us/squeeze-page-10262753, to review the "Offering Circular," which contains an extensive list of significant risks that should be fully understood prior to considering any investment in this Emerging Growth Company or otherwise. Further, it is vital that everyone interested in this industry complete their own independent review of all associated and significant legal, regulatory, economic and market risks.

For additional information about Advantameds Solutions USA Fund 1, Inc. direct investment offering, contact the Company at 1-844-420-Fund (1-844-420-3863) or Rich Kaiser, Investor Relations, YES INTERNATIONAL, 757-306-6090, and yes@yesinternational.com.

Forward-looking Statements:
This news release contains certain statements that may constitute forward-looking information within the meaning of applicable securities laws. This information includes, but is not limited to (i) The Company's ability to fully raise $50,000,000; and (ii) legal rules in the medical marijuana industry remaining consistent at the time of this release. Although AdvantaMeds Solutions USA Fund 1, Inc. believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because management can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to some factors and risks.

Image Available: http://www.marketwire.com/library/MwGo/2016/10/25/11G119423/Images/amedpot-0b141e1ccd57a9b884a2175d3a9adccd.jpg